Suicide gene therapy in head and neck carcinoma cells: An in vitro study

International Journal of Molecular Medicine

Volumn 27, Issue 4, 2011, Pages 591-597

  Schmidt, Marianne ^a   Gruensfelder, Petra ^a   Roller, Jeanette ^a   Hagen, Rudolf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

GeneSwitch; Head and neck cancer; Pseudomonas exotoxin A; Suicide gene therapy

Indexed keywords

ANTIBIOTIC AGENT; MIFEPRISTONE; PSEUDOMONAS EXOTOXIN; PSEUDOMONAS EXOTOXIN A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CLONING; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE INDUCTION; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HYPOPHARYNX CARCINOMA; IN VITRO STUDY; MUTANT; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SUICIDE GENE; SUICIDE GENE THERAPY; TRANSGENICS;

ADP RIBOSE TRANSFERASES; BACTERIAL TOXINS; CARCINOMA; CELL LINE, TUMOR; EXOTOXINS; GENE EXPRESSION REGULATION; GENE ORDER; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; NEOPLASMS, SQUAMOUS CELL; VIRULENCE FACTORS;

EID: 79952227194     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.610     Document Type: Article

References (18)

1. Schmidt M, Heimberger T, Gruensfelder P and Schier G: Inducible promoters for gene therapy of head and neck cancer: an in vitro study. Eur Arch Otorhinolaryngol 261: 208-215, 2004. (Pubitemid 38561484)
2. Wang Y, O'Malley BW Jr, Tsai SY and O'Malley BW: A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 91: 8180-8184, 1994. (Pubitemid 24253910)
3. Burcin MM, Schiedner G, Kochanek S, Tsai SY and O'Malley BW: Adenovirus-mediated regulable target gene expression in vivo. Proc Natl Acad Sci USA 96: 355-360, 1999. (Pubitemid 29061212)
4. Abruzzese RV, Godin D, Mehta V, Perrard JL, French M, Nelson W, Howell G, Coleman M, O'Malley BW and Nordstrom JL: Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system. Mol Ther 2: 276-287, 2000.
5. Sirin O and Park F: Regulating gene expression using self-inactivating lentiviral vectors containing the mifepristone-inducible system. Gene 323: 67-77, 2003. (Pubitemid 37501086)
6. Bertram J: MATra - Magnet Assisted Transfection: combining nanotechnology and magnetic forces to improve intracellular delivery of nucleic acids. Curr Pharm Biotechnol 7: 277-285, 2006.
7. McFarland D: Preparation of pure cell cultures by cloning. Methods Cell Sci 22: 63-66, 2000.
8. Wels W, Harwerth I-M, Mueller M, Groner B and Hynes N Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res 52: 6310-6317, 1992.
9. Yerushalmi N, Brinkmann U, Brinkmann E, Pai L and Pastan I: Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes. Cancer Gene Ther 7: 91-96, 2000. (Pubitemid 30080992)
10. Azemar M, Schmidt M, Arlt F, Kennel P, Brandt B, Papadimitriou A, Groner B and Wels W: Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo. Int J Cancer 86: 269-275, 2000. (Pubitemid 30180824)
11. Wels W, Baldrich M, Chakraborty T, Gross R and Goebel W: Expression of bacterial cytotoxin genes in mammalian target cells. Mol Microbiol 6: 2651-2659, 1992.
12. Martin V, Cortes ML, de Felipe P, Farsetti A, Calcaterra NB and Izquierdo M: Cancer gene therapy by thyroid hormone-mediated expression of toxin genes. Cancer Res 60: 3218-3224, 2000. (Pubitemid 30407920)
13. Ye X, Schillinger K, Burcin MM, Tsai SY and O'Malley BW: Ligand-inducible transgene regulation for gene therapy. Methods Enzymol 346: 551-561, 2002. (Pubitemid 41103158)
14. Osterwalder T, Yoon KS, White BH and Keshishian H: A conditional tissue-specific transgene expression system using inducible GAL4 Proc Natl Acad Sci USA 98: 12596-12601, 2001.
15. Draghia-Akli R, Malone PB, Hill LA, Ellis KM, Schwartz RJ and Nordstrom JL: Enhanced animal growth via ligand-regulated GHRH myogenic-injectable vectors. FASEB J 16: 426-428, 2002.
16. Chen Q, He Y and Yang K: Gene therapy for Parkinson's disease: progress and challenges. Curr Gene Ther 5: 71-80, 2005. (Pubitemid 40246742)
17. Wang XJ, Liefer KM, Tsai S, O'Malley BW and Roop DR: Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci USA 96: 8483-8488, 1999. (Pubitemid 29354817)
18. Ngan ES, Schillinger K, DeMayo F and Tsai SY The mifepristone-inducible gene regulatory system in mouse models of disease and gene therapy. Semin Cell Dev Biol 13: 143-149, 2002. (Pubitemid 35300826)